Taken together, treatment with EGCG partially reverses the damage of DA neuron degeneration induced by rotenone to improve motor impairments via promoting PKD1 and inhibiting neuronal Parthanatos, suggesting the effect of EGCG on the treatment of PD. Here, PKD1 is linked to Parkinson disease.